Active, not recruitingPHASE1, PHASE2NCT04270838

A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG

Studying Rabies

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Oxford
Principal Investigator
Alexander D Douglas
Jenner Institute
Intervention
ChAdOx2 RabG(biological)
Enrollment
174 target
Eligibility
2-45 years · All sexes
Timeline
20222028

Study locations (1)

Collaborators

Ifakara Health Institute

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04270838 on ClinicalTrials.gov

Other trials for Rabies

Additional recruiting or active studies for the same condition.

See all trials for Rabies

← Back to all trials